Ticker Details
Enanta Pharmaceuticals, Inc. Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Group uses its chemistry-driven approach & drug discovery capabilities to develop its products.
IPO Date:	March 21, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$328M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.91 | 2.40%
Avg Daily Range (30 D):	$0.39 | 2.90%
Avg Daily Range (90 D):	$0.36 | 2.65%

Institutional Daily Volume
Avg Daily Volume:	.2M
Avg Daily Volume (30 D):	.16M
Avg Daily Volume (90 D):	.14M

Trade Size
Avg Trade Size (Sh.):	72
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	48

Institutional Trades
Total Institutional Trades:	2,645
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$.72M
Avg Institutional Trade (90 D):	$.68M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.9M
Avg Closing Trade (30 D):	$.52M
Avg Closing Trade (90 D):	$.61M
Avg Closing Volume:	39.32K

News

Sep 29, 2025 @ 5:35 PM 10 Health Care Stocks With Whale Alerts In Today's... Source: Benzinga Staff Writer

Sep 29, 2025 @ 5:28 PM Enanta's RSV Pill Shows Promise In Cutting Recover... Source: Vandana Singh

Sep 29, 2025 @ 5:06 PM 12 Health Care Stocks Moving In Monday's Intraday ... Source: Benzinga Staff Writer

Sep 26, 2025 @ 9:06 PM 12 Health Care Stocks Moving In Friday's After-Mar... Source: Benzinga Staff Writer

Jun 11, 2025 @ 9:07 PM FDA Expands AbbVie's Mavyret Label To Include Acut... Source: Vandana Singh

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-2.6	$-.45	$-.42
Diluted EPS	$-2.6	$-.45	$-.42
Revenue	$69.21M	$17.16M	$18.62M
Gross Profit
Net Income / Loss	$-61.98M	$-13.09M	$-11.94M
Operating Income / Loss	$-60.38M	$-11.85M	$-11.25M
Cost of Revenue
Net Cash Flow	$-25.29M	$-2.51M	$5.14M
PE Ratio